Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Depression 3Breast Neoplasms 3Brain Neoplasms 3Anxiety Disorders 3Pain, Postoperative 2Urinary Bladder Neoplasms 1Stroke 1Prostatic Neoplasms 1Pain 1Ovarian Neoplasms 1Meningioma 1Erectile Dysfunction 1Emergence Delirium 1Delirium 1Carcinoma, Renal Cell 1Agnosia 1Advanced Ovarian Cancer 1

Interventions

Specimen Handling 8Nivolumab 6pembrolizumab 4lenvatinib 3Ipilimumab 3Biopsy 3Axitinib 3vorolanib 2fludarabine 2cabozantinib 2anlotinib 2Sunitinib 2Nephrectomy 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2CTLA-4 Antigen 2toripalimab 1tivozanib 1sodium-iodide symporter 1sintilimab 1pazopanib 1fludarabine phosphate 1cemiplimab 1bemarituzumab 1belzutifan 1balstilimab 1Zoledronic Acid 1Saline Solution 1Rubidium-82 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Renal Cell × Saline Solution × Clear all
NCT06146777 2023-11-29

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

First Affiliated Hospital, Sun Yat-Sen University

Phase 3 Not yet recruiting
468 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡